Trial Details
TERMINATEDBasic Information
| Clinical ID | c2290 |
|---|---|
| Identifier | NCT03724175 |
| Trial Title | The Role of Secondary Bile Acids in Intestinal Inflammation |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis|Pouchitis |
| Interventions | DRUG: ursodiol (ursodeoxycholic acid, UDCA) |
Participant Information
| Sponsor | Stanford University |
|---|---|
| City | Stanford |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2|PHASE3 |
Time Information
| Start Date | 2019-08-26 |
|---|---|
| Primary Completion Date | 2026-03-02 |
| Completion Date | 2026-03-02 |